Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Pfaller

Showing results (311-320 of 542) with videos related to

Pageof 55
Sort By:
The Journal of Antimicrobial Chemotherapy|December 16, 1998
In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella sppM A Croco, D J Biedenbach, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 1999
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance ProgramG V Doern, M A Pfaller, M E Erwin, et al.
Infection Control and Hospital Epidemiology|July 1, 1995
Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unitA I Hartstein, M A Denny, V H Morthland, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1991
The clinical microbiology laboratory as an aid in infection control. The application of molecular techniques in epidemiologic studies of methicillin-resistant Staphylococcus aureusM A Pfaller, D S Wakefield, R Hollis, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepimeR N Jones, D J Biedenbach, S A Marshall, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Evaluation of endpoints for antifungal susceptibility determinations with LY303366M E Klepser, E J Ernst, M E Ernst, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 1998
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE ProgramM A Pfaller, R N Jones, S A Messer, et al.
Infection Control and Hospital Epidemiology|January 1, 1993
Restriction endonuclease analysis of plasmid DNA from methicillin-resistant Staphylococcus aureus: clinical application over a three-year periodA Trilla, M D Nettleman, R J Hollis, et al.
Journal of Clinical Microbiology|April 1, 1996
Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazoleJ H Rex, M A Pfaller, M Lancaster, et al.
Journal of Clinical Microbiology|May 8, 2003
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazoleM A Pfaller, D J Diekema, L Boyken, et al.
Pageof 55

Showing results (311-320 of 542) with videos related to

Sort By:
Pageof 55
The Journal of Antimicrobial Chemotherapy|December 16, 1998
In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella sppM A Croco, D J Biedenbach, M A Pfaller, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 1999
The prevalence of fluoroquinolone resistance among clinically significant respiratory tract isolates of Streptococcus pneumoniae in the United States and Canada--1997 results from the SENTRY Antimicrobial Surveillance ProgramG V Doern, M A Pfaller, M E Erwin, et al.
Infection Control and Hospital Epidemiology|July 1, 1995
Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unitA I Hartstein, M A Denny, V H Morthland, et al.
Diagnostic Microbiology and Infectious Disease|May 1, 1991
The clinical microbiology laboratory as an aid in infection control. The application of molecular techniques in epidemiologic studies of methicillin-resistant Staphylococcus aureusM A Pfaller, D S Wakefield, R Hollis, et al.
Diagnostic Microbiology and Infectious Disease|November 21, 1998
Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepimeR N Jones, D J Biedenbach, S A Marshall, et al.
Antimicrobial Agents and Chemotherapy|June 13, 1998
Evaluation of endpoints for antifungal susceptibility determinations with LY303366M E Klepser, E J Ernst, M E Ernst, et al.
Diagnostic Microbiology and Infectious Disease|May 23, 1998
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE ProgramM A Pfaller, R N Jones, S A Messer, et al.
Infection Control and Hospital Epidemiology|January 1, 1993
Restriction endonuclease analysis of plasmid DNA from methicillin-resistant Staphylococcus aureus: clinical application over a three-year periodA Trilla, M D Nettleman, R J Hollis, et al.
Journal of Clinical Microbiology|April 1, 1996
Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazoleJ H Rex, M A Pfaller, M Lancaster, et al.
Journal of Clinical Microbiology|May 8, 2003
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazoleM A Pfaller, D J Diekema, L Boyken, et al.
Pageof 55